Patanjali has ‘cures’ for incurable diseases but no clinical evidence

The company says its ayurvedic medicines can cure dozens of ailments that modern medicine can’t. Experts say such claims are misleading and, at times, illegal.

18 August, 202211 min
0
Patanjali has ‘cures’ for incurable diseases but no clinical evidence

Why read this story?

Editor's note: Patanjali Ayurved has declared war on allopathy. The latest salvo came on 10 July, through half-page advertisements in newspapers across India. Titled “Misconceptions spread by allopathy”, it listed 20 ailments—a mix of lifestyle disorders and chronic illnesses—that can’t be cured by modern medicine, only controlled. “We have cured thousands of people of these incurable and life-threatening diseases and have provided scientific evidence to back up the efficacies of our treatments,” the advertisement said. To demonstrate, it listed the ayurvedic medicine manufactured by Patanjali that helped “cure” each of the 20 ailments. These were to be accompanied by the practice of yoga and pranayama as well as other dietary interventions, like consuming giloy juice. A photo of the Patanjali's advertisement published on July 10 in several newspapers across India. Photo credit: @AnantBhan/Twitter Baba Ramdev, co-founder and the face of the Haridwar-based FMCG and pharmaceutical company, took it a notch higher at the International Conference on Modernization of Traditional Indian Medicine. The conference was held in the first week of August at the Patanjali Research Institute. “All other diseases that we know …

You may also like

Business
Story image

Can India finally rein in misleading claims in advertisements?

The Supreme Court has mandated all advertisers to submit self-declarations certifying that their ads had no bogus claims. Easier said than implemented.

Chaos
Story image

What happened when I lost my Twitter account

The moment my account was withheld, my world of learning came crashing down, but then came a sudden realization.

Business
Story image

Ramdev hits pay dirt on the market

A successful offer for sale, soon after an FPO, helps his Patanjali group recoup nearly twice what it paid for acquiring Ruchi Soya.